Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.4 Fte (4)
Lobbyists with EP accreditation
0
High-level Commission meetings
5
Lobbying Costs over the years
-
Info
BioNTech SE
EU Transparency Register
516273537966-42 First registered on 04 May 2020
Goals / Remit
Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline, including the Cominarty® Covid-19 vaccine and the first ever approved mRNA drug product.
Main EU files targeted
Interactions with the European Commission regarding activities relating to mRNA drugs and vaccines, including its COVID-19 vaccine.
Address
Head Office
An der Goldgrube 12
Mainz 55131
GERMANYEU Office
An der Goldgrube 12
Mainz 55131
GERMANYWebsite
-
People
Total lobbyists declared
4
Employment time Lobbyists 10% 4 Lobbyists (Full time equivalent)
0.4
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Ana PANCHEVSKA 12 Jan 2024 04 Oct 2024 Constanze BLUME 12 Jan 2024 04 Oct 2024 Complementary Information
N/A
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
American Association for Cancer Research
American Chamber of Commerce in Germany e.V.
American Society for Mass Spectrometry
American Society of Clinical Oncology
American Society of Tropical Medicine and Hygiene
Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V.
Association of American Physicians
Biotechnologie-Industrie-Organisation Deutschland e.V. (BIO Deutschland e. V.)
Bundesdeutscher Arbeitskreis für Umweltbewusstes Management (B.A.U.M.) e.V.
Bundesverband Materialwirtschaft, Einkauf und Logistik e.V. (BME)
Chambre de Commerce et D’Industrie France-Amerique
Cluster for Individualized Immune Intervention (Ci3) e.V.
DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.
DIRK – Deutscher Investor Relations Verband e. V.
DSAG - Deutschsprachige SAP-Anwendergruppe e.V.
econsense – Forum Nachhaltige Entwicklung der Deutschen Wirtschaft e. V.
European Confederation for Pharmaceutical Entrepreneurs (EUCOPE)
European Society for Medical Oncology
Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.
gesundheitswirtschaft rhein-main e. V.
Hessenchemie – Arbeitgeberverband Chemie und verwandte Industrien für das Land Hessen e. V.
IHK - Industrie- und Handelskammer zu Berlin
IHK - Industrie- und Handelskammer Halle-Dessau
IHK - Industrie- und Handelskammer für Koblenz
IHK - Industrie- und Handelskammer für München und Oberbayern
IHK - Industrie- und Handelskammer für Rheinhessen
International Society for Advancement of Cytometry
International Society for Cell & Gene Therapy
Initiative Gesundheitsindustrie Hessen (IGH)
Kita Bio Regio e.V.
Mainzer Wissenschaftsallianz e.V.
Massachusetts Biotechnology Council
Max Bergmann Kreis e.V.
Project Management Institute
Research Quality Association Ltd.
Singapore Business Federation
Society for Immunotherapy of Cancer
The Alliance for mRNA Medicines (AMM)
The American Association of Pharmaceutical Scientists
The Foundation for the Global Compact
The National Association for EHS&S Management
Verband der Chemischen Industrie e.V. (VCI)
Verband Forschender Arzneimittelhersteller e. V.; vfa
Vereinigung für Sicherheit in der Wirtschaft e.V.
Vienna BioCenter – Wissenschaftliche Standortgemeinschaft
Women in Bio
Zentrale zur Bekämpfung unlauteren Wettbewerbs e.V.Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount kenup foundation 0€ - 10,000€ fipra international srl 10,000€ - 24,999€ Intermediaries for current year
Name fipra international srl Closed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
N/A
Other activities
None declared
Meetings
Meetings
5 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 22 Feb 2024 Location online Subject Presentation of their global health activities DG Directorate-General for International Partnerships Attending - Koen Doens (Director-General)
-
Date 27 Jun 2023 Location Brussels Subject social Europe, skills, industrial strategy Cabinet Cabinet of Commissioner Nicolas Schmit Portfolio Jobs and Social Rights Attending - Christoph Nerlich (Cabinet member)
-
Date 06 Jan 2022 Location Videoconference Subject Meeting with CEO of BioNTech Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
-
Date 06 May 2021 Location Marburg Germany Subject Site visit and assessment of production capacity and supply chain Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists